Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$6.27B
sum of reported positions
Reported positions
833
Changes vs prior quarter
994
141 new · 267 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 299 measured positions in 6 quarters, the typical new or larger position finished −3.3 pts against the S&P 500 and 39% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 1.05M | $146M | 2.3% | |
| 333K | $83.8M | 1.3% | |
| 223K | $76.6M | 1.2% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $6.73B | $6.27B |
| Positions | 959 | 833 |
| Biggest line | — | Intel 2% |
| 957K |
| $74.9M |
| 1.2% |
| 403K | $73M | 1.2% |
| 696K | $71.2M | 1.1% |
| 76K | $70.7M | 1.1% |
| 176K | $69.9M | 1.1% |
| 514K | $69.6M | 1.1% |
| 922K | $68.6M | 1.1% |
| 1.66M | $68.6M | 1.1% |
| 65K | $68.2M | 1.1% |
| 396K | $66.5M | 1.1% |
| 680K | $65.3M | 1.0% |
| 236K | $65.1M | 1.0% |
| 409K | $62M | 1.0% |
| 660K | $60.5M | 1.0% |
| 571K | $59.1M | 0.9% |
| 151K | $54.8M | 0.9% |
| 849K | $54.5M | 0.9% |
| 185K | $54.3M | 0.9% |
| 1.57M | $50.2M | 0.8% |
| 642K | $49.9M | 0.8% |
| 176K | $49.9M | 0.8% |
| 268K | $48.2M | 0.8% |
Treace Medical Concepts (TMCI)
137K → 88K shares (−36%)
Arrivent Biopharma (AVBP)
12K → 9,670 shares (−21%)
Anaptysbio (ANAB)
36K → 4,882 shares (−86%)
Atrenew (RERE)
95K → 84K shares (−11%)
Mercantile Bank (MBWM)
8,811 → 5,590 shares (−37%)
Ionis Pharmaceuticals (IONS)
96K → 3,935 shares (−96%)
Amc Global Media (AMCX)
101K → 31K shares (−69%)
J&J Snack Foods Corp. (JJSF)
16K → 4,200 shares (−73%)
Virgin Galactic Holdings (SPCE)
263K → 105K shares (−60%)
Universal Health Realty Income Trust (UHT)
9,260 → 6,880 shares (−26%)
Stoke Therapeutics (STOK)
119K → 8,775 shares (−93%)
Natural Resource Partners LP (NRP)
3,200 → 2,900 shares (−9%)
Rocky Brands (RCKY)
8,864 → 6,746 shares (−24%)
Ingersoll Rand (IR)
29K → 3,366 shares (−89%)
Betterware de Mexico (BWMX)
16K → 15K shares (−5%)
Boston Omaha (BOC)
25K → 20K shares (−21%)
Universal Insurance Holdings (UVE)
18K → 6,516 shares (−64%)
Dingdong (Cayman) (DDL)
349K → 135K shares (−61%)
Powell Industries, Inc. (POWL)
2,023 → 900 shares (−56%)
WHITESTONE REIT
38K → 13K shares (−65%)
Lyell Immunopharma (LYEL)
21K → 18K shares (−14%)
Compass Minerals International (CMP)
41K → 7,819 shares (−81%)
Natures Sunshine Products (NATR)
13K → 11K shares (−17%)
Smartfinancial (SMBK)
9,545 → 4,938 shares (−48%)
Methode Electronics (MEI)
17K → 12K shares (−31%)
